Article
Microcystin-LR ameliorates pulmonary fibrosis via modulating CD206+ M2-like macrophage polarization.
Cell death & disease - 19 Feb 2020
Wang Jie, Xu Lizhi, Xiang Zou, Ren Yan, Zheng Xiufen, Zhao Qingya, Zhou Qunzhi, Zhou Yuefen, Xu Lin, Wang Yaping
Abstract excerpt
Idiopathic pulmonary fibrosis (IPF) is a group of chronic interstitial pulmonary diseases characterized by myofibroblast proliferation and extracellular matrix deposition with limited treatment options. Based on our previous observation, we hypothesized microcystin-leucine arginine (LR), an environmental cyanobacterial toxin, could potentially suppress pulmonary fibrosis. In this study, we first demonstrated that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
